Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Sensei Biotherapeutics, Inc. (SNSE) had Current Assets of $41.93M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-30.16M |
|
-- |
|
-- |
|
$32.61M |
|
$-32.61M |
|
$2.46M |
|
$-30.16M |
|
$-30.16M |
|
$-30.16M |
|
$-30.16M |
|
$-30.16M |
|
$-30.16M |
|
$-32.61M |
|
$-31.29M |
|
25.12M |
|
25.12M |
|
$-1.20 |
|
$-1.20 |
|
Balance Sheet Financials | |
Current Assets |
$41.93M |
$0.42M |
|
$3.43M |
|
$45.36M |
|
$5.45M |
|
$0.10M |
|
$1.53M |
|
$6.97M |
|
$38.39M |
|
$38.39M |
|
$38.39M |
|
25.18M |
|
Cash Flow Statement Financials | |
$-24.67M |
|
$22.44M |
|
$-0.79M |
|
$13.01M |
|
$9.99M |
|
$-3.02M |
|
$3.13M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.70 |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-78.56% |
|
-78.56% |
|
-66.48% |
|
-78.36% |
|
$1.52 |
|
$-0.99 |
|
$-0.98 |